News Conference News AHA 2018 EWTOPIA 75: Ezetimibe Bests Dietary Counseling Alone in Lowering Cardiovascular Risk for Elderly Japanese Patients Yael L. Maxwell November 16, 2018
News Conference News AHA 2018 Alirocumab Should Be Priced at $6,300 Annually: ODYSSEY Cost-Effectiveness Study Michael O'Riordan November 15, 2018
News Conference News VIVA 2018 Consulting the COMPASS for Rivaroxaban’s Role in Peripheral Vascular Disease L.A. McKeown November 15, 2018
News Conference News AHA 2018 Long-term FREEDOM: At Nearly 8 years, CABG Maintains Mortality Benefit Over PCI Michael O'Riordan November 14, 2018
News Conference News AHA 2018 TiCAB: Ticagrelor No Help for Preventing Graft Failure Post-CABG Shelley Wood November 13, 2018
News Conference News AHA 2018 Novel Inhibitor of Apolipoprotein(a) Production Lowers Lp(a) in Phase II Study Shelley Wood November 11, 2018
News Conference News AHA 2018 Post-MI Yoga: Randomized Trial Shows Feasibility and Safety as an Option for Cardiac Rehab Yael L. Maxwell November 10, 2018
News Conference News AHA 2018 DECLARE-TIMI 58 Supports HF Benefit of SGLT2 Inhibitors Todd Neale November 10, 2018
News Conference News AHA 2018 Methotrexate, an Anti-inflammatory, Fails to Lower Risk of Cardiovascular Events: CIRT Michael O'Riordan November 10, 2018
News Conference News AHA 2018 REDUCE-IT: Prescription Fish Oil Prevents CV Events in Patients With High Triglycerides Todd Neale November 10, 2018
News Conference News AHA 2018 VITAL: No Benefits to Vitamin D and Omega-3s in Reducing Major CV Events, Cancer Shelley Wood November 10, 2018
News Daily News Lower Hypertension Range Tied to Heightened CVD Risk in Younger Adults Todd Neale November 08, 2018
News Daily News ODYSSEY Outcomes Published as New Cholesterol Guidelines Loom Michael O'Riordan November 07, 2018
News Daily News Statins Provide No Clinical Benefit When Coronary Calcium Is Zero, Study Shows Michael O'Riordan November 06, 2018
News Daily News Low Incidence of A-fib Seen in Elite Athletes, Including Runners and Triathletes Michael O'Riordan November 02, 2018
News Daily News Diabetes Drug Canagliflozin Gets MACE Reduction Indication Todd Neale November 01, 2018
News Daily News FDA Puts the Kibosh on Canakinumab for Cardiac Indication—at Least for Now Michael O'Riordan November 01, 2018
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for October 2018 Shelley Wood October 31, 2018
News Daily News Study Questions Role of BP Meds in Patients With Hypertension but No Other CVD Risk Factors L.A. McKeown October 30, 2018